| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |